CORRECTION article

Front. Mol. Biosci., 13 October 2022

Sec. Nanobiotechnology

Volume 9 - 2022 | https://doi.org/10.3389/fmolb.2022.1046852

Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies

  • 1. Department of Biomedical Engineering, SKKU Institute for Convergence, Sungkyunkwan University, Suwon, South Korea

  • 2. Department of Intelligent Precision Healthcare Convergence, SKKU Institute for Convergence, Sungkyunkwan University, Suwon, South Korea

  • 3. Department of Chemistry, Sungkyunkwan University, Suwon, South Korea

  • 4. Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States

  • 5. Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, United States

  • 6. Department of Biomedical Engineering, McCormick School of Engineering, Evanston, IL, United States

  • 7. Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, United States

  • 8. College of Pharmaceutical Sciences, Institute of Pharmaceutics, Zhejiang University, Hangzhou, China

  • 9. College of Pharmaceutical Sciences, Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, China

  • 10. Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, South Korea

In the published article, an author name was incorrectly written as “Wonhaw Lee.” The correct spelling is “Wonhwa Lee.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

reactive oxygen species (ROS), nanotechnology, disease treatment and diagnosis, pyroptosis, aging

Citation

Park CG, Lee W, Kim D-H, Li F and Park W (2022) Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies. Front. Mol. Biosci. 9:1046852. doi: 10.3389/fmolb.2022.1046852

Received

17 September 2022

Accepted

20 September 2022

Published

13 October 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2022

Updates

Copyright

*Correspondence: Wooram Park,

This article was submitted to Nanobiotechnology, a section of the journal Frontiers in Molecular Biosciences

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics